Active regulatory elements within CD4+ T cells harbor disproportionate heritability (h2) for rheumatoid arthritis (RA). We hypothesized that regulatory elements specific to pathogenic CD4+ T cell-states better capture RA h2; however, defining these elements is challenging. To this end, we introduce IMPACT, a genome annotation strategy to identify cell-state-specific regulatory elements defined by key transcription factor binding profiles, learned from 398 chromatin and sequence annotations. Integrating IMPACT annotations of four
It is now well recognized that complex trait diseases have disproportionate heritability (h2) in subsets of genes and regulatory elements, particularly those that are specifically expressed in pathogenic cell and tissue types. For example, genetic studies of rheumatoid arthritis (RA), which is an autoimmune disease attacking synovial joint tissue leading to permanent joint damage and disability 1 , have suggested a critical role by CD4+ T cells [2] [3] [4] [5] [6] [7] [8] [9] [10] . However, developing safe and effective therapeutics requires knowledge of the key cellular subsets, or cell-states, underlying disease risk and their regulatory elements. Naive CD4+ T cells may differentiate into memory T cells, and then into effector T cells Th(T helper)1, Th2, and Th17 and T regulatory (Treg) cells, requiring the action of a limited number of key transcription factors (TFs): T-bet or Stat4, Gata3 or Stat6, Stat3 or ROR-gamma-t, FoxP3 or Stat5, respectively 11 . Recently, we and others have identified CD4+ T cell-states significantly associated with RA: Tph (T peripheral helper) 12 and Th1 super-effector 13 cells.
We hypothesized that regulatory elements specific to pathogenic CD4+ T cell-states capture RA h2 better than cell-state-nonspecific CD4+ T cell elements. However, defining cell-state-specific gene regulatory elements is challenging; identification of active promoters and enhancers through open chromatin assays in the cell-state of interest will highlight both cell-state-specific and nonspecific regulatory elements.
To overcome this challenge, we take a two-step approach where we first choose a (Table S1 ) assayed in immune, muscular, skeletal, brain, and other cell types, while sequence features include coding, intergenic, etc.
From this regression we learn a TF binding chromatin profile, which we use to probabilistically define other genomic regions as cell-state-specific regulatory elements at nucleotide-resolution, distinguishing from nonspecific or non-regulatory elements ( Figure 1A) .
We used IMPACT to predict regulatory elements in four CD4+ T cell-states: Th1, Th2, Th17, and Treg, in each case selecting a single regulator based on availability of high quality genome-wide TF occupancy data (ChIP-seq): T-bet, Gata3, Stat3, and FoxP3, respectively ( Table S2) [14] [15] [16] [17] [18] . IMPACT predicts TF occupancy at binding motifs with high accuracy (mean AUC 0.94 (s.e. 0.03), 10-fold cross validation performed on 80% of training data, AUC evaluated on the withheld 20%, Figure 1B, Figure S1 , Table S3 ).
We find that cell-state-specific chromatin features are often the most important predictor variables (Figure S2) . IMPACT performs significantly better than naive strategies that predict TF motif binding based on active promoters (H3K4me3 ChIP-seq) or cell-statespecific open chromatin (DNase-seq) (all p<1.5e-15, Figure 1B) . Restricting feature categories in the model, such as removing cell-state-specific features or features of the same epigenomic assay, revealed that only Th2 prediction accuracy significantly declines from exclusion of Th2-specific features ( Table S3 ). While experimental binding data from ChIP-seq can only identify broad regions of binding signal (~300 bp), IMPACT provides nucleotide resolution, illustrated by predictions at canonical TF-specific targets ( Figure 1C, Figure S3 ). We find that IMPACT annotations are highly correlated with To test our hypothesis that IMPACT captures RA h2, we used stratified LD (linkage disequilibrium) score regression (S-LDSC) 9 with publicly available European (EUR, N = 38,242) 9 and East Asian (EAS, N = 22,515) 19 RA GWAS summary statistics to partition the common SNP h2 of RA, which is estimated to be about 18% for EUR and 21% for EAS (Methods: S-LDSC). We computed CD4+ T cell-state-specific (Th1, Th2, Th17, and Treg) regulatory element probabilities at all common SNPs (MAF ≥ 0.05) genomewide, excluding the major histocompatibility complex (MHC) due to its outlier LD structure. We then created S-LDSC models, composed of one or more IMPACT annotations and a set of 69 baseline annotations, controlling for cell-type-nonspecific functional, LD-related, and MAF associations, referred to as the baseline-LD model 20 .
We found that each CD4+ T cell-state-specific IMPACT annotation is significantly enriched with RA h2 in both populations (average enrichment = 20.05, all p<1.9e-04, Figure 2A , Table S4 ). The standardized annotation effect size, *, is defined as the proportionate change in per-SNP h2 associated with a one standard deviation increase in the value of the annotation. The * of an annotation that captures RA h2 will be significantly greater than zero and the greater the *, the more that annotation captures RA h2. * is significantly positive for all CD4+ IMPACT annotations (all p<2.1e-03, Figure 2B , conditional analysis in Figure S5 ), demonstrating that IMPACT captures RA h2 not explained by the baseline-LD annotations. We then created annotations consisting of the top 5% of regulatory SNPs according to each IMPACT cell-state and show that the Treg annotation explains the greatest proportion of RA h2, 84.0% (s.e. 17.1%) in Europeans and 88.6% (s.e. 22.3%) in East Asians (Figure 2C) . Lastly, we show that while IMPACT annotations are strongly correlated with one another, they are weakly correlated with baseline-LD annotations (Figure 2D) , consistent with significantly positive * in Figure 2B .
We hypothesized that the CD4+ T cell-state IMPACT annotations would capture RA h2 better than other T cell functional annotations. To this end, we compared the enrichments and * of each CD4+ IMPACT annotation to that of various functional annotations, in EUR: TF binding motifs, genome-wide TF occupancy (ChIP-seq), an annotation that assigns each SNP a value proportional to the number of IMPACT epigenomic features it overlaps (Averaged Tracks), the five largest * CD4+ T cellspecific histone mark annotations 9 , the five largest * CD4+ T cell-specifically expressed gene sets and their regulatory elements 6 , and T cell super enhancers 21 (Figure 3,   Figure S6 ). Then, we computed the annotation * while pairwise conditioned on each other and on baseline-LD. We found that, even when conditioned on annotations with highly significant enrichment, the CD4+ Treg and Th2 IMPACT * are significantly positive (all p<0.01) and are more significant, thereby capturing RA h2 better than all other annotations, except H3K27ac in Th2 cells.
We next hypothesized that IMPACT would inform functional variant fine-mapping. Using a GWAS of 11,475 European RA cases and 15,870 controls 22 , an independent study from the European summary statistics 23 used in our h2 analyses, our group recently fine-mapped a subset of 20 RA risk loci, each with a manageable number of putatively causal variants, and created 90% credible sets of these SNPs 24 . We computed the enrichment of fine-mapped causal probabilities across these 20 loci in the top 1% of our CD4+ T cell-state-specific IMPACT annotations (Methods: Posterior Probability Enrichment). We found that only the Treg annotation is significantly enriched (2.87, permutation p<8.6e-03, Figure 4A , Table S5 ), suggesting this annotation may be useful to prune putatively causal RA variants. Furthermore, we observe uniquely high Treg enrichment in the BACH2 and IRF5 loci (16.2 and 8.1, respectively), suggesting putatively causal SNPs in these loci may function in a Treg-specific context.
In related work, our group observed both differential binding of CD4+ nuclear extract via EMSA and differential enhancer activity via luciferase assays at two credible set SNPs, narrowing down the list of putatively causal variants in the CD28/CTLA4 and TNFAIP3 loci 24 . We observed that both variants with functional activity were located at predicted IMPACT regulatory elements, suggesting that IMPACT may be used to narrow down credible sets to reduce the amount of experimental follow up. First, at the CD28/CTLA4 locus, we observe high probability regulatory elements across the four CD4+ T cellstates at the functional SNP rs117701653 and lower probability regulatory elements at other credible set SNPs rs55686954 and rs3087243 ( Figure 4B) . Second, at the TNFAIP3 locus, we observe high probability regulatory elements at the functional SNP rs35926684 and other credible set SNP rs6927172 ( Figure 4C ) and do not predict regulatory elements at the other 7 credible set SNPs. The CD4+ Th1 specific regulatory element at rs35926684 suggests that this SNP may alter gene regulation specifically in Th1 cells and hence, we suggest any functional follow-up be done in this cell-state. Few other credible set SNPs in the other 18 fine-mapped loci have high IMPACT cell-state-specific regulatory element probabilities ( Figure S7 ). We note that disease-relevant IMPACT functional annotations may be integrated with existing functional fine mapping methods, like PAINTOR 25 , to assign causal posterior probabilities to variants.
We then applied our CD4+ T IMPACT annotations to 41 additional polygenic traits 20, 26 and observed significantly positive * for autoimmune traits, Crohn's and ulcerative colitis (both p<0.04), and several blood traits, eosinophil and white blood cell counts (both p<0.02), but not for non-immune-mediated traits ( Figure 5 , Table S6 ). For comparison, we built an HNF4A (hepatocyte nuclear factor 4A) IMPACT annotation to target LDL and HDL, liver-associated traits 27 . As expected, HNF4A IMPACT * is not significant for autoimmune-mediated traits, but is significantly positive for LDL and HDL (both p<0.02), suggesting that IMPACT can find complex trait associated regulatory elements specific to a range of cell types.
In summary, IMPACT predicts cell-state-specific regulatory elements based on chromatin profiles of experimental TF binding and may help elucidate complex trait biology. First, we observed highly significant enrichments of RA h2 in IMPACT regulatory elements and explain the majority of RA h2 with just the top 5%. Second, we found that IMPACT annotations capture RA h2 better than most CD4+ T cell functional annotations. Lastly, we have briefly shown another utility of IMPACT to narrow down credible sets to reduce functional follow-up. We recognize several limitations to our work: 1) we have not experimentally validated the activity of any of our predicted regulatory elements, 2) predicted regulatory elements are limited to genomic regions that have been epigenetically assayed, 3) while IMPACT models appear unique between cell-states in terms of which epigenomic features best indicate TF motif binding, predicted regulatory element probabilities across cell-states are highly correlated due to the correlated nature of epigenomic features. In light of these limitations, IMPACT is an emerging strategy for identifying trait associated regulatory elements and generating hypotheses about the cell-states in which variants may be functional, motivating the need to develop therapeutics that target specific diseasedriving cell-states.
Methods

Rationale
To explore if we could predict cell-state-specific regulatory elements, we selected RA and CD4+ T cells as the trait and cell type for our model because multiple lines of evidence support the role of CD4+ T cells in the pathogenesis of RA. First, classical HLA typing studies implicated the MHC region 2 , more recently fine-mapped to the individual amino acid residues of HLA-DRB1 3 , which presents antigens to CD4+ T cells.
Second, we 7,8 and others 9,10 have demonstrated that there is an enrichment of RA causal variation in active regulatory elements of CD4+ T cells. Similarly, genes within RA risk loci are enriched for specific expression in CD4+ T cells 5 and genes expressed specifically within CD4+ T cell subpopulations are enriched for RA h2 9 . Finally, recent fine-mapping efforts have identified putatively causal variants within the CD28/CTLA4
and TNFAIP3 loci that have differential enhancer effects in-vivo 24 .
Data
Genome-wide Annotation Data. We obtained publicly available genome-wide annotations in a broad range of cell types for the GRCh37 (hg19) assembly. The accession numbers and or file names for features downloaded from NCBI, Blueprint, Roadmap, and chromHMM are listed in Table S1 . Features from Finucane et al 2015 9 are labeled as they were in supplemental tables of this study. Cell-type-specific annotation types include ATAC-seq, DNase-seq, FAIRE-seq, HiChIP, polymerase and elongation factor ChIP-seq, and histone modification ChIP-seq. Sequence annotations were downloaded from UCSC's publicly available bedfiles and include conservation, exons, introns, intergenic regions, 3'UTR, 5'UTR, promoter-TSS, TTS, and CpG islands). All genome-wide feature data, except conservation, is represented in standard 6-column bedfile format. Conservation is represented in bedgraph format, in which the average score is reported for each 1024 bp window genome-wide.
TF ChIP-seq data. We determined genome-wide TF occupancy from publicly available ChIP-seq (Table S2) ChIP-seq peaks were called by macs 28 [v1.4.2 20120305] (FDR<0.05).
IMPACT Model
We build a model that predicts TF binding on a motif by learning the epigenomic profiles of the TF binding sites. We use logistic regression to model the log odds of TF binding based on a linear combination of the effects $ of the j epigenomic features, where % is an intercept.
From the log odds, which ranges from negative to positive infinity, we compute the probability of TF binding, ranging from 0 to 1. We use an elastic net logistic regression framework implemented by the cv.glmnet R [v1.0.143] package 29 , in which optimal are fit according to the following objective function,
We use a regularization strategy to constrain the values of and help prevent overfitting.
Elastic net regularization is a compromise between the lasso (L1) and ridge (L2)
penalties. Both penalties have advantageous effects on the model fit of j features. Lasso performs feature selection, allowing only a subset to be used in the final model, pushing some $ to 0, which is useful for large feature sets such as IMPACT and avoids overfitting. When used alone, lasso will arbitrarily select one of several correlated features to be included in the final model; incorporating the ridge term limits this effect of lasso. Furthermore, ridge provides a quadratic term, making the optimization problem convex with a single optimal solution. The elastic net logistic regression has the following parameters: alpha, lambda, and type. Alpha is the mix term between the lasso and ridge penalties in the objective function, which controls the sparsity of betas. We set alpha to 0.5, such that the L1 and L2 terms equally contribute, correlated features may be retained to some degree, and not too many betas are pushed to 0. We set lambda to lambda.min, the value of λ that yields minimum mean cross-validated error, and type set to response, such that our predictions are in probability space rather than log odds space.
Training IMPACT. We train IMPACT on gold standard regulatory and non-regulatory elements of a particular TF, meaning that there is one IMPACT model per TF/cell-state pair. To build the regulatory class, we scanned the TF ChIP-seq peaks, mentioned above, for matches to the TF-specific binding motif, using HOMER 30 [v4.8.3] . Each match must receive a sequence similarity score greater than or equal to the threshold provided by the PWMs (position weight matrices) in the Jaspar database (Table S2) .
We only scan for the TF motif of the corresponding TF ChIP-seq dataset, e.g. we only looked for T-bet motifs in the T-bet ChIP-seq data. We retained the highest scoring motif match for each ChIP-seq peak and used the genomic coordinates of the center two nucleotides to create a GenomicRanges object in R. For the T-bet data, there were 10,086 such ranges, 1,224 for Gata3, 1,181 for Stat3, and 1,005 for FoxP3. For every run of IMPACT, 1,000 regulatory ranges are randomly selected, labeled with a 1, to train the model. Controlling the number of ranges used will standardize the logistic regression output such that predictions and model fits will be more comparable between cell-state models.
To build the non-regulatory class, we scanned the entire genome for TF motif matches, again using HOMER, and selected motif matches with no overlap with that TF's ChIPseq peaks, e.g. we scan for T-bet motifs, and only retain regions not overlapping T-bet ChIP-seq peaks. We do not check for overlap with other TF (i.e. Gata3, Stat3, FoxP3)
ChIP-seq peaks. Similarly to the regulatory set, we used the genomic coordinates of the center two nucleotides of retained motifs to create the non-regulatory set, and label them as 0 in the regression. The motif matching process in both classes serves as a modest control for sequence content, as motifs are conserved regions of DNA. For every run of IMPACT, 10,000 regions of the non-regulatory set are randomly selected to train the model. This value is one order of magnitude larger than the regulatory set to reflect that genome-wide, we expect far more non-regulatory than regulatory elements.
We justify setting this value to 10,000 if we assume that ~10% of the genome is regulatory, then for every positive region, we need nine negative regions. This would require 9*1,000 regulatory elements = 9,000 non-regulatory elements, a conservative estimate of the number of non-regulatory elements we actually use.
The sets of regulatory and non-regulatory elements are first partitioned into a random sampling of 80% each, to be used for 10-fold cross validation (CV), in which these sets are further partitioned into 90%/10% train/test. The remaining 20% to be used as a validation set (data completely unseen by the CV).
IMPACT is trained on standard 6-column bedfiles, of regions that are 2 base pairs wide, Feat. X We applied IMPACT genome-wide to assign nucleotide-resolution regulatory probabilities, using the model learned from the elastic net logistic regression CV.
Model from the run of IMPACT used to produce genome-wide annotations as well as the averaged model over 10 runs can be found in Table S1 . We show the largest magnitude for each cell-state IMPACT model in Figure S2 .
Stratified-LD Score Regression (S-LDSC)
Genome-wide association data. We collected RA GWAS summary statistics 23 Methodology. We apply S-LDSC 9 [v1.0.0], a method developed to partition polygenic trait heritability by one or more functional annotations, to quantify the contribution of IMPACT cell-state-specific regulatory annotations to RA and other autoimmune disease heritability. We annotate common SNPs (MAF ≥ 0.05) with multiple cell-state-specific IMPACT models, assigning a regulatory element score to each variant. Then S-LDSC was run on the annotated SNPs to compute LD scores. Here, the two statistics we use to evaluate each annotation's contribution to disease heritability are enrichment and standardized effect size ( *).
If a cj is the value of annotation c for SNP j, we assume the variance of the effect size of SNP j depends linearly on the contribution of each annotation c: However, the * for the annotation with greater true causal variant membership will be larger and more statistically significant (e.g. > 0). Specifically, a * of 0, means that the annotation does not change per-SNP h2. A strongly negative * means that membership to the categorical annotation decreases per-SNP h2, while a strongly positive * means that membership to the annotation increases per-SNP h2. The significance of * is computed based on a test of how different from 0 the * is.
MHC exclusion. We note that S-LDSC excludes the MHC (major histocompatibility complex) due to its extremely high gene density and outlier LD structure, which is thought to be the strongest contributor to RA disease h2 13 . However, our work supports the notion that there is an undeniably large amount of RA h2 located outside of the MHC.
Posterior probability enrichment
Previous work from our group aimed to define the most likely causal RA variant for each locus harboring a genome-wide significant variant 24 . To this end, posterior probabilities were computed with the approximate Bayesian factor (ABF), assuming one causal variant per locus. The posteriors were defined as:
where i is the i th variant, and n is the total number of variants in the locus. As such, the ABF over all variants in a locus sum to 1. Then, for each of the defined 20 RAassociated loci 24 , we computed the enrichment of high posterior probabilities in the top 1% of cell-state-specific IMPACT regulatory elements (Table S5) Tregs, and 75% other T lymphocytes, we expected more FoxP3 binding in the Tregs relative to the other cells, and as such our TF occupancy profile should predominantly reflect that of Tregs. As there is especially poor availability of TF occupancy data in nonimmune primary cells, we encourage the generation of more of this cell-state-specific
data. Furthermore, due to IMPACT's skew toward immune cell type features (~50%), we recommend supplementing relevant cell-type-specific features to avoid overfitting to immune cell types.
Data Availability
All code for this paper has been made publicly available in the following GitHub (a) IMPACT learns a chromatin profile of cell-type-specific regulation, characteristic of the master regulator TF (red) "gold standard" regulatory elements (TF motif and ChIPseq peak, yellow) and non-regulatory elements (TF motif, no ChIP-seq peak, purple). In RA SNPs. For two RA-associated loci, CTLA4/CD28 and TNFAIP3, we examine the putatively causal SNP with experimentally validated differential enhancer activity (bolded) and other 90% credible set SNPs (unbolded) 24 . IMPACT scores at these SNPs are highlighted with a black line. (b) We observe high probability IMPACT regulatory elements in all four CD4+ T cell-states for the functional SNP rs117701653 in the CD28/CTLA4 locus. (c) We observe a high probability Th1-specific IMPACT regulatory element for the functional SNP rs35926684 in the TNFAIP3 locus. 
